Search Results - "Schiavello, E."
-
1
Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy
Published in Child's nervous system (01-11-2017)“…Purpose An intensive therapeutic strategy for metastatic medulloblastoma was launched in 1998 in our Institution. The aim of this study was to examine the…”
Get full text
Journal Article -
2
Management of breast cancer after Hodgkin’s lymphoma and paediatric cancer
Published in European journal of cancer (1990) (01-09-2015)“…Abstract Rationale The risk of women developing a breast cancer (BC) after receiving chest radiotherapy for paediatric cancers and Hodgkin lymphomas is well…”
Get full text
Journal Article -
3
OC-0346: Pediatric diffuse intrinsic pontine glioma re-irradiation: better survival and better time
Published in Radiotherapy and oncology (01-04-2016)Get full text
Journal Article -
4
PO-0856: Clinical and dosimetric issues of VMAT craniospinal irradiation for paediatric medulloblastoma
Published in Radiotherapy and oncology (01-04-2016)Get full text
Journal Article -
5
EP-1531: Image registration framework to investigate children neurocognitive outcome after focal brain irradiation
Published in Radiotherapy and oncology (01-04-2015)Get full text
Journal Article -
6
O10.10 RESULTS OF NIMOTUZUMAB AND VINORELBINE, RADIATION AND RE-IRRADIATION FOR DIFFUSE PONTINE GLIOMA IN CHILDHOOD
Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)“…BACKGROUND: Radiotherapy is the only treatment definitely indicated for diffuse pontine gliomas (DIPG). Data on the role of EGFR signaling in the onset of…”
Get full text
Journal Article -
7
-
8
P06.01 Pediatric non-pontine diffuse midline glioma H3K27M mutant: a monoinstitutional experience
Published in Neuro-oncology (Charlottesville, Va.) (09-09-2021)“…Abstract BACKGROUND The new entity “diffuse-midline-glioma H3K27M-mutant”(DMG) was defined in the 2016 WHO classification. This tumor subtype, regardless of…”
Get full text
Journal Article -
9
090 - TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Published in Leukemia research (01-10-2022)Get full text
Journal Article -
10
TREATING LYMPHOMA IN THE PANDEMIC ERA: WHAT WE LEARNED FROM OUR EXPERIENCE AT FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Published in Leukemia research (01-10-2022)Get full text
Journal Article -
11
PO-0872 Hematological toxicity of 3DCRT and VMAT craniospinal irradiatiation in pediatric medulloblastoma
Published in Radiotherapy and oncology (01-04-2019)Get full text
Journal Article -
12
P14.77 Reduced dose craniospinal irradiation (CSI) is feasible for standard risk adult medulloblastoma (MBL) patients similarly to pediatric population
Published in Neuro-oncology (Charlottesville, Va.) (06-09-2019)“…Abstract BACKGROUND MBL is the most common malignant pediatric brain tumor but represents 1% of adult brain tumors. Recent molecular classification suggests…”
Get full text
Journal Article -
13
50. Retrospective study of late radiation damages after focal radiotherapy for childhood brain tumors
Published in Physica medica (01-12-2018)“…Investigate late radiation damages after focal radiotherapy (RT) for childhood brain cancer in terms of neurocognitive outcome. 45 retrospective children (age…”
Get full text
Journal Article -
14
Nimotuzumab and vinorelbine concomitantly to radiation and as maintenance for diffuse pontine glioma in childhood: Results from a series of 12 patients
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
15
O10.10RESULTS OF NIMOTUZUMAB AND VINORELBINE, RADIATION AND RE-IRRADIATION FOR DIFFUSE PONTINE GLIOMA IN CHILDHOOD
Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)“…BACKGROUND: Radiotherapy is the only treatment definitely indicated for diffuse pontine gliomas (DIPG). Data on the role of EGFR signaling in the onset of…”
Get full text
Journal Article -
16
Use of myeloablative Y90-ibritumomab tiuxetan in patients with high-risk CD20+ NHL not eligible for standard ASCT: Five-year results
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
17
QUALITY OF LIFE/AFTERCARE
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2014)Get full text
Journal Article -
18
EPENDYMOMA
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2014)Get full text
Journal Article -
19
MEDULLOBLASTOMA
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2012)Get full text
Journal Article -
20
EPENDYMOMA
Published in Neuro-oncology (Charlottesville, Va.) (01-06-2012)Get full text
Journal Article